Marilyn Matz (Director) sold ~$508K of Teradyne
Scheduled in advanceLoading…
Traded May 15, 2026 · Filed May 19, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Marilyn Matz (Director) sold ~$508K of Teradyne
Scheduled in advanceGregory Stephen Smith (President and CEO) sold ~$1.69M of Teradyne
Scheduled in advanceTraded Jun 12 · filed 5 days later
Not classified as an open-market trade.